Amgen Inc.
AMGN
$269.12
-$2.19-0.81%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.55B | 6.68B | 5.85B | 6.55B | 6.24B |
| Total Other Revenue | 355.00M | 303.00M | 259.00M | 287.00M | 415.00M |
| Total Revenue | 6.90B | 6.99B | 6.11B | 6.84B | 6.65B |
| Cost of Revenue | 1.81B | 1.81B | 1.72B | 1.75B | 1.59B |
| Gross Profit | 5.10B | 5.17B | 4.39B | 5.09B | 5.06B |
| SG&A Expenses | 1.34B | 1.29B | 1.26B | 1.57B | 1.29B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -9.00M | 57.00M | 2.00M | -7.00M | 11.00M |
| Total Operating Expenses | 4.22B | 4.26B | 4.04B | 4.64B | 4.00B |
| Operating Income | 2.69B | 2.73B | 2.07B | 2.20B | 2.65B |
| Income Before Tax | 1.95B | 1.61B | 3.44B | 1.75B | 2.39B |
| Income Tax Expenses | 217.00M | 235.00M | 601.00M | 132.00M | 249.00M |
| Earnings from Continuing Operations | 1.73B | 1.38B | 2.84B | 1.62B | 2.14B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.73B | 1.38B | 2.84B | 1.62B | 2.14B |
| EBIT | 2.69B | 2.73B | 2.07B | 2.20B | 2.65B |
| EBITDA | 3.58B | 3.62B | 2.97B | 3.11B | 3.49B |
| EPS Basic | 3.23 | 2.58 | 5.32 | 3.02 | 4.01 |
| Normalized Basic EPS | 2.84 | 1.11 | 4.12 | 2.49 | 2.56 |
| EPS Diluted | 3.22 | 2.57 | 5.28 | 2.99 | 3.98 |
| Normalized Diluted EPS | 2.82 | 1.11 | 4.09 | 2.47 | 2.55 |
| Average Basic Shares Outstanding | 535.00M | 535.00M | 534.00M | 535.00M | 535.00M |
| Average Diluted Shares Outstanding | 538.00M | 537.00M | 538.00M | 539.00M | 538.00M |
| Dividend Per Share | 2.13 | 2.13 | 2.13 | 1.94 | 1.94 |
| Payout Ratio | 65.90% | 82.60% | 40.02% | 64.36% | 48.44% |
